Sanofi Cancels Consumer Healthcare Business Spin-Off

Photographer: Nathan Laine/Bloomberg© 2024 Bloomberg Finance LPDeal Overview On October 21, 2024, Sanofi (NASDAQ: SNY US (ADR), $53.83, Market Cap:$136.6 billion, EN Paris: SAN FP, €100.04, Market Cap: €126.9 billion) announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella. Opella is Sanofi’s consumer healthcare business unit focusing on over-the-counter medicines, vitamins, minerals, and s ...